Organogenesis Holdings (ORGO) Inventory Average (2019 - 2026)

Organogenesis Holdings' Inventory Average history runs 8 years deep, the most recent figure standing at $29.0 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 4.49% year-over-year to $29.0 million in Q1 2026; TTM through Mar 2026 was $29.0 million, a 4.49% increase from a year earlier, with the FY2025 full-year figure at $27.9 million, up 2.52% from the prior year.
• Inventory Average retreated to $29.0 million in Q1 2026 per ORGO's latest filing, from $34.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $36.3 million in Q3 2025 and bottomed at $23.0 million in Q2 2022.
• The 5-year median for Inventory Average is $27.0 million (2024), against an average of $27.6 million.
• Across the five-year window, Inventory Average fell 20.5% in 2022 and jumped 34.69% in 2025, its largest moves.
• Year by year, Inventory Average stood at $24.7 million in 2022, then grew by 13.53% to $28.1 million in 2023, then slipped by 5.17% to $26.6 million in 2024, then grew by 29.96% to $34.6 million in 2025, then fell by 16.12% to $29.0 million in 2026.
• Per Business Quant, the three latest ORGO Inventory Average figures stand at $29.0 million (Q1 2026), $34.6 million (Q4 2025), and $36.3 million (Q3 2025).